Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Cingulate Inc

CING
Current price
3.85 USD -0.09 USD (-2.28%)
Last closed 4.04 USD
ISIN US17248W1053
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 14 216 265 USD
Yield for 12 month -96.16 %
1Y
3Y
5Y
10Y
15Y
CING
21.11.2021 - 28.11.2021

Cingulate Inc., a biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of attention deficit/hyperactivity disorder and anxiety in the United States. The company's stimulant medications are CTx-1301 (dexmethylphenidate), which is in phase 3 clinical trial, as well as CTx-1302 (dextroamphetamine), which is in investigational new drug application development for the treatment of attention deficit/hyperactivity disorder intended for children, adolescents, and adults. It also focuses on developing CTx-2103 that is in a formulation stage for the treatment of anxiety. The company was founded in 2012 and is headquartered in Kansas City, Kansas. Address: 1901 West 47th Place, Kansas City, KS, United States, 66205

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

80.33 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

-3 849 997 128 USD

Current Year

-582 918 USD

Last Year

-621 993 USD

Current Quarter

-3 206 180 000 USD

Last Quarter

-2 948 217 USD

Key Figures CING

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -18 046 852 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -225.77 %
PEG Ratio
Return On Equity TTM -1364.73 %
Wall Street Target Price 80.33 USD
Revenue TTM
Book Value 3.95 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM -8 995 280 USD
Earnings per share -326.4 USD
Diluted Eps TTM -326.4 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics CING

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History CING

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:12
Payout Ratio
Last Split Date 09.08.2024
Dividend Date

Stock Valuation CING

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -0.3641
Price Book MRQ 4.3139

Financials CING

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators CING

For 52 weeks

1.8 USD 152.4 USD
50 Day MA 6.34 USD
Shares Short Prior Month 27 862
200 Day MA 12.13 USD
Short Ratio 0.23
Shares Short 38 266
Short Percent 1.3 %